Market revenue in 2023 | USD 87.8 million |
Market revenue in 2030 | USD 158.2 million |
Growth rate | 8.8% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Pharmaceuticals |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceuticals, Devices |
Key market players worldwide | Johnson & Johnson, Cipla Ltd DR, Sun Pharmaceutical Industries, Merck & Co Inc, Dr. Reddy’s Laboratories, Cardiff Lexington Corp, Amgen Inc, Theradome, Aurobindo Pharma, Curallux, Apira Science |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to androgenetic alopecia market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 98.52% in 2023. Horizon Databook has segmented the Spain androgenetic alopecia market based on pharmaceuticals, devices covering the revenue growth of each sub-segment from 2018 to 2030.
In Spain, alopecia affects over 40% of the population, causing physical and psychological distress. The alopecia epidemiological data suggest that nearly 50% of the women suffer from alopecia by the age of 50. Topical minoxidil and oral finasteride are approved drugs for treating AGA in Spain.
The androgenetic alopecia market in Spain is mainly driven by new product launches and an active R&D pipeline. For instance, new excipient forms of finasteride, dutasteride, and oral minoxidil are under review. In addition, Janus Kinase (JAK) inhibitors and androgens are under investigation for treating different types of alopecia.
Furthermore, the local players are focusing on adopting diverse strategies, such as mergers & acquisitions, product developments, and research collaborations, aiding market growth. For instance, Capillus, LLC collaborated with Svenson, a hair loss treatment clinic, to expand the distribution of laser therapy caps in Spain and Portugal.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain androgenetic alopecia market , including forecasts for subscribers. This country databook contains high-level insights into Spain androgenetic alopecia market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account